Rehabilitation Program for Spastic Ataxia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a special 12-week rehabilitation program designed to help individuals with spastic ataxias, a condition that affects walking and balance. The study compares the effects of this new program, called IMPACT (rehabIlitation prograM for sPAstiC aTaxias), against regular care to determine if it reduces disease severity and to explore its implementation in real-world settings. Participants will either continue with their usual care or join the program, which includes therapy sessions and aquatherapy (water-based exercises) three times a week. Individuals with spastic ataxias who can stand and move with assistance may be suitable for this trial. As an unphased trial, this study provides a unique opportunity to contribute to innovative rehabilitation strategies that could enhance the quality of life for those with spastic ataxias.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on a rehabilitation program rather than medication changes.
What prior data suggests that this rehabilitation program is safe for individuals with spastic ataxias?
Research has shown that the IMPACT rehabilitation program for spastic ataxias is safe and manageable for participants. In a previous study, participants experienced noticeable improvements in balance, walking, and daily activities without serious side effects. Other studies support these findings, indicating that personalized rehabilitation programs can effectively reduce symptoms while remaining safe and acceptable for patients. This program aims to help people with spastic ataxias, conditions that cause walking and balance problems, and has shown promising results in enhancing their quality of life.12345
Why are researchers excited about this trial?
Researchers are excited about the IMPACT rehabilitation program for spastic ataxias because it offers a structured, intensive approach that isn't typically available with the current standard of care. Unlike typical treatments that might involve sporadic physiotherapy and occupational therapy sessions, this program involves a consistent schedule of three sessions per week over 12 weeks, incorporating both traditional therapy and aquatherapy. This comprehensive and regular regimen could potentially lead to more significant improvements in mobility and daily functioning for patients with spastic ataxia.
What evidence suggests that the IMPACT rehabilitation program is effective for spastic ataxia?
Research has shown that a special rehabilitation program for spastic ataxias yields promising results. In earlier studies, participants experienced significant improvements in balance, walking, and daily activities after completing the program. Another study found that personalized home exercises reduced ataxia symptoms and improved balance. Evidence supports that rehabilitation can enhance posture in people with cerebellar ataxias. In this trial, participants in the intervention group will follow the IMPACT rehabilitation program, which may effectively lessen disease symptoms and improve daily life for those with spastic ataxias.12345
Who Is on the Research Team?
Elise Duchesne, Ph D.
Principal Investigator
Université du Québec à Chicoutimi
Are You a Good Fit for This Trial?
This trial is for individuals with spastic ataxias, a group of conditions causing walking difficulties and balance problems. Participants should have these symptoms but not be undergoing any other specific treatments for them during the trial.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants in the intervention group will follow a 12-week rehabilitation program, 3 times a week (two sessions in a therapy room and one session of aquatherapy).
Follow-up
Participants are monitored for safety and effectiveness after treatment, with various assessments conducted over a 64-week period.
What Are the Treatments Tested in This Trial?
Interventions
- IMPACT - rehabIlitation prograM for sPAstiC aTaxias
Find a Clinic Near You
Who Is Running the Clinical Trial?
Université du Québec à Chicoutimi
Lead Sponsor
Centre intégré universitaire de santé et de services sociaux du Saguenay-Lac-St-Jean
Collaborator
Integrated University Health and Social Services Center of the Capitale-Nationale
Collaborator
Corporation de recherche et d'action sur les maladies héréditaires (CORAMH)
Collaborator
University of Alberta
Collaborator
Muscular Dystrophy Canada
Collaborator
Cégep de Jonquière
Collaborator
Université du Québec a Montréal
Collaborator
University of Calgary
Collaborator
Université de Sherbrooke
Collaborator